arrow
S

Shervin Gholizadeh

Genentech
H指数:16
被引数:802

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice

成年水通道蛋白-4免疫球蛋白G血清阳性视神经脊髓炎谱系障碍患者中的萨特拉利珠单抗治疗在临床实践中的应用

2025-12-090
OA
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series

Satralizumab治疗在AQP4-IgG血清阳性的视神经脊髓炎谱系障碍患者中的应用:一项病例系列研究

2025-06-010
PRE
Long-term Safety of Satralizumab in Adults with Aquaporin-4-IgG-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from SAkuraMoon

Satralizumab在Aquaporin-4-IgG-seropositive (AQP4-IgG) 视神经脊髓炎谱系障碍 (NMOSD) 成人中的长期安全性: SAkuraMoon的结果

2023-04-250
PRE